These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 9632722)
1. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722 [TBL] [Abstract][Full Text] [Related]
2. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155 [TBL] [Abstract][Full Text] [Related]
3. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078 [TBL] [Abstract][Full Text] [Related]
4. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. Liu Y; Zhong X; Li W; Brattain MG; Banerji SS J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860 [TBL] [Abstract][Full Text] [Related]
8. Sp3 is a transcriptional repressor of transforming growth factor-beta receptors. Ammanamanchi S; Brattain MG J Biol Chem; 2001 Feb; 276(5):3348-52. PubMed ID: 11027677 [TBL] [Abstract][Full Text] [Related]
9. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells. Ammanamanchi S; Tillekeratne MP; Ko TC; Brattain MG Cancer Res; 2004 Apr; 64(7):2509-15. PubMed ID: 15059906 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation. Jakowlew SB; Moody TW; Mariano JM Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation. Hypes MK; Pirisi L; Creek KE Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999 [TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells. Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930 [TBL] [Abstract][Full Text] [Related]
13. Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine. Zhang Q; Rubenstein JN; Liu VC; Park I; Jang T; Lee C Life Sci; 2005 Jan; 76(10):1159-66. PubMed ID: 15620579 [TBL] [Abstract][Full Text] [Related]
14. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428 [TBL] [Abstract][Full Text] [Related]
16. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis. Jakowlew SB; Moody TW; You L; Mariano JM Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100 [TBL] [Abstract][Full Text] [Related]
17. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells. Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891 [TBL] [Abstract][Full Text] [Related]
18. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines. Nørgaard P; Spang-Thomsen M; Poulsen HS Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260 [TBL] [Abstract][Full Text] [Related]
19. Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues. Wu G; Fan RS; Li W; Srinivas V; Brattain MG J Biol Chem; 1998 Mar; 273(13):7749-56. PubMed ID: 9516484 [TBL] [Abstract][Full Text] [Related]
20. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]